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Abstract The aims of this investigation were to isolate active ingredients from the roots/rhizomes of Cyperus articulatus
used as herbal medicine in Cameroon for the treatment of human onchocerciasis and to assess the efficacy of the
metabolites on the Onchocerca worm. The antifilarial activity was evaluated in vitro on microfilariae (Mfs) and adult
worms of the bovine derived Onchocerca ochengi, a close relative of Onchocerca volvulus. Cytotoxicity was assessed
in vitro on monkey kidney epithelial cells. The structures of the active compounds were determined using spectroscopic
methods and their drug-likeness evaluated using Lipinski parameters. Two secondary metabolites, AMJ1 [containing
mustakone (1) as the major component] and linoleic acid or (9Z,12Z)-octadeca-9,12-dienoic acid (2) were isolated. Both
compounds were found to kill both the microfilariae and adult worms of O. ochengi in a dose dependent manner. The IC50s
for AMJ1 were 15.7 lg/mL for Mfs, 17.4 lg/mL for adult males and 21.9 lg/mL for adult female worms while for linoleic
acid the values were, 15.7 lg/mL for Mfs, 31.0 lg/mL for adult males and 44.2 lg/mL for adult females. The present
report provides the first ever evidence of the anti-Onchocerca efficacy of AMJ1 and linoleic acid. Thus, these secondary
metabolites may provide a lead for design and development of new antifilarial agents.
Keywords Cyperus articulates  Linoleic acid  Microfilariae  Mustakone  Onchocerca ochengi  Onchocerca
volvulus
1 Introduction
Human onchocerciasis or subcutaneous filariasis is a par-
asitic disease caused by the filarial worm Onchocerca
volvulus. It is transmitted through the bites of infected
blackflies of Simulium species, which carry immature lar-
val forms of the parasite from human to human. In the
human body, the larvae form nodules in the subcutaneous
tissue, where they mature to adult worms. After mating, the
female adult worm can release up to 1000 microfilariae a
day. These move through the body, and when they die they
cause a variety of conditions, including blindness, skin
rashes, lesions, intense itching and skin depigmentation [1].
About 37 million persons are infected with O. volvulus, of
whom 270000 are blind and 500000 visually impaired with
about 90 million vulnerable to get the disease [2, 3]. The
burden of onchocerciasis causes long term disability, social
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stigmatization and leads to a highly unproductive popula-
tion and consequently to economic loss and slowdown of
country development over the years since the affected
population is forced to abandon the infested areas which
usually have a high agricultural potential [4].
Ivermectin (IVM), the sole drug used in community-
directed treatment of onchocerciasis is microfilaricidal and
with only limited activity against the adult worms. Parasite
resistance to IVM and adverse reactions observed in
patients co-infected with Loa loa limit the use of the drug
[3]. To date, the only known macrofilaricide for oncho-
cerciasis is suramin but it is toxic. There is need to develop
safe and easily administered drugs that can kill the adult
O. volvulus parasite to reduce the time needed for control
programs to eliminate adult worms from an endemic area.
Rational drug discovery approaches have made only lim-
ited advances in the discovery of a safe macrofilaricide
against the Onchocerca worm. It has been suggested that
plants used in folk medicine to treat parasitic diseases may
provide an alternative source of macrofilaricides [5]. Pre-
vious studies in our laboratory showed that the hexane
extract of the roots/rhizomes of Cyperus articulatus (used
as herbal medicine in Cameroon to treat onchocerciasis)
was active against the microfilariae and adult worms of the
bovine parasite Onchocerca ochengi, a close relative of the
medically important O. volvulus. C. articulatus (family:
Cyperaceae) is a bushy grass mainly found along tropical
rivers and streams. The present studies aimed at isolating
pure compounds from the hexane extract (essential oil) of
the roots/rhizomes of the plant and evaluate their anti-
Onchocerca activity and drug-likeness.
2 Results
2.1 Identification of Secondary Metabolites Isolated
from the Hexane Extract of Cyperus articulatus
The roots/rhizomes of C. articulatus were extracted with
hexane. Column chromatography of this extract as descri-
bed in the Experimental section afforded two compounds
(Fig. 1) which were identified with the help of 1H and 13C
NMR spectra as well as by comparison of these data with
published literature values for mustakone [6, 7] and linoleic
acid [8].
2.2 Identification of AMJ1
AMJ1 was obtained as white oil. The ESI-MS (ESM Fig. S1)
of AMJ1 revealed the presence of three compounds with a
major compound with peak at 219.1. In fact, its 1H NMR
spectrum showed a peak at 5.71 ppm characteristic of an
olefinic proton deshielded by inductive effect of a carbonyl
group. Other protons resonated at d 1.50–1.70 ppm corre-
sponding to axial and equatorial protons of a cyclohexane
ring. The 13C NMR spectrum (ESM Table S1) showed the
signals of the 15 carbon atoms amongst others. Comparing
the 1H and 13C NMR data of mustakone (1) [6, 7] with
those of AMJ1, further confirmed the structure, mustak-
one which was previously isolated from the rhizomes of















Fig. 1 Structures of the






















Fig. 2 Effect of compounds from C. articulatus essential oil (hexane
extract) on O. ochengi microfilariae (MF), adult male (AM) and adult
female (AF) worms after 20 h incubation. The lower the IC50 value
the more effective the compound
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2.3 Identification of AMJ2
AMJ2 was obtained as white oil. Its 1H NMR spectrum
showed signals characteristic of olefinic protons at
d 5.34–5.40, a methylene protons at d 2.79 sandwiched
between two sp2 carbon atoms and a methylene proton
next to a carbon bearing an acid function at d 2.34 (ESM
Table S2). Other protons resonated at d 2.00–1.25 corre-
sponding to methylene protons and methyl protons up field
at d 0.88. Its 13C NMR spectrum showed 18 carbon atoms
and revealed the presence of a carbonyl signal at d 180.4
(C-1). The other signals were in close agreement with lit-
erature values [8]. Comparing these 1H NMR and 13C
NMR data with those of linoleic acid [8] further confirmed
the structure of AMJ2 to be linoleic acid (2) which was
previously isolated from Hydrangea chinensis [8].
2.4 Effect of Isolated Metabolites on O. ochengi
Microfilariae and Adult Worms, and Monkey
Kidney Epithelial Cells (LLC-MK2) in Secondary
Screens
The concentration that causes 50 % growth inhibition
(IC50) in O. ochengi microfilariae and adult worms, that
which causes 100 % inhibition (IC100) as well as the
selectivity indices against monkey kidney epithelial cells
(LLC-MK2) in secondary screens are shown in Table 1,
meanwhile Table 2 shows the effects of isolated secondary
metabolites (AMJ1 and linoleic acid) on O. ochengi
microfilariae and adult worms, and monkey kidney epi-
thelial cells (LLC-MK2) in secondary screens. AMJ1 is
more active on adult worms (lower IC50 values) than lin-
oleic acid (Table 2; Fig. 2). Both metabolites exhibit
greater activity on adult male than on adult female worms.
A comparison of the effects of the two isolated metabolites
on O. ochengi microfilariae (MF), adult male (AM) and
adult female (AF) worms after 20 h incubation is shown in
the histograms on Fig. 2.
For microfilariae (Mfs) and adult male worms IC50
corresponds to the concentration of the phytochemical that
inhibits worm motility by 50 % while for adult female
worms, IC50 is the concentration of the metabolite that
inhibits formazan formation by 50 %. IC50 for mammalian
cells (monkey kidney cells) is the concentration of the
metabolite that inhibits cell viability by 50 %. SI (Selec-
tivity Index) = IC50 on mammalian cells/IC50 on parasite.
IC100 is the concentration of the bioactive metabolite that
inhibits O. ochengi Mfs and adult male worm motility or
formazan formation by adult female worms by 100 %.
2.5 In Silico ‘‘Drug-likeness’’ Profile of Plant-Derived
Compounds with Anti-onchocerca Activity
Lipinski et al. [9] postulated the ‘‘rule of five’’, which states
that a compound will likely not be orally bioavailable if its
molecular weight (MW) is [500 Daltons (Da), its n-octa-
nol/water partition coefficient (log P) [5, its number of
H-bond acceptors (HBA) [10 and its number of H-bond
donors (HBD) [5. An additional rule for the number of
rotatable bonds (NRB) is often added to Lipinski’s rule in
order to take drug metabolism and pharmacokinetics into
account, since this parameter is known to influence bio-
availability in rats [10]. The above parameters were used to
initially access the likely oral bioavailability of the isolated
compounds. Lipinski evaluation showed that whereas lin-
oleic acid shows only one violation of the Lipinski rule,
mustakone had no violation (Table 3).
3 Discussion
Onchocerciasis causes intense itching, blurred vision and
sometimes irreversible blindness. Rational drug discovery
approaches have made only limited advances in the dis-
covery of a safe macrofilaricide against the Onchocerca
worm [11]. It has been suggested that medicinal plants used
Table 1 IC50, IC100 and selectivity indices (SI) of mustakone and octadeca-9,12-dienoic acid on O. ochengi microfilariae and adult worms, and
monkey kidney epithelial cells (LLC-MK2) in secondary screens
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in folk medicine to treat parasitic diseases may provide an
alternative source of macrofilaricides [5]. We here report
the efficacy of AMJ1 [containing mustakone (1) as major
component] and linoleic acid [(9Z,12Z)-octadeca-9,12-di-
enoic acid] (2) isolated from the essential oil (hexane
extract) of the roots/rhizomes of C. articulatus against
microfilariae and adult O. ochengi worms, the closest rel-
ative and best model of the human parasite, O. volvulus
[11]. Thus, it is feasible that compounds that are active
against the bovine parasite will also affect the human
parasite, O. volvulus. The effect of these metabolites on the
Onchocerca worm seems to be specific since other com-
pounds tested under similar conditions were ineffective
(results not shown). AMJ1-containing mustakone was more
active in vitro than linoleic acid on adult male and female
worms. The combined effect of these two metabolites may
explain in part the apparent anti-Onchocerca activity of
decoctions of C. articulatus and justifies the use of this
plant as traditional medicine for the treatment of human
onchocerciasis. However due to the difficulty in obtaining
very pure compounds from oils, it may be necessary to
further evaluate the anti-onchocerca activity of these
compounds by using commercially produced samples.
Furthermore HPLC techniques should be used to separate
AMJ1 to determine the active principle in it. Mustakone, a
sesquiterpene previously isolated by Nyasse et al. [6, 7] has
been shown to exhibit anti-plasmodial activity [12]. Lino-
leic acid has also been reported to have anti-bacterial [13]
and antifungal activity [14]. We here report for the first
time their activity against the Onchocerca worm. Lipinski
evaluation shows that these compounds are potential drug
leads against onchocerciasis.
4 Experimental Section
4.1 General Experimental Procedures
1H and 13C NMR spectra were recorded at 500 and
125 MHz, respectively, on a Bruker ARX- 500 spec-
trometer. The 1H and 13C NMR chemical shifts are
expressed in ppm relative to TMS. Chemical shifts were
recorded in d (ppm) and the coupling constants (J) are in
hertz. Thin-layer chromatography (TLC) was performed
on Merck silica gel plates. TLC plates were visualized
with a UV-lamp (UVGL-58) at 254 or 366 nm and later
exposed to iodine. Column chromatography was per-
formed with glass columns using either silica gel 60–200
mesh or Sephadex LH-20. The relative molecular mass
was obtained from Electron Spray Ionisation Mass
Spectroscopy (ESI-MS) in the positive mode (Water). The
analysis was obtained using a Nucleodur C18 Pyramid
column (Macherey_Nagel).
4.2 Isolation of Pure Compounds from the Hexane
Extract of the Roots/Rhizomes of Cyperus
articulatus
4.2.1 Plant Material
Cyperus articulatus was collected from inland valleys at
Sehn village, Ndu Sub-Division in the North West Region
of Cameroon, based on ethno pharmacological informa-
tion. The local name of the plant is ‘‘Ndfu’’. The voucher
specimen was deposited at the National herbarium in
Yaounde´ and assigned voucher number 19450/SRF-CAM.
The roots/rhizomes of the plant were separated from the
stem, air dried and ground to fine powder.
Table 2 Effect of compounds from roots/rhizomes of C. articulatus
on viability of O. ochengi microfilariae (Mfs) and adult worms at
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a The gold-conjugated compound, NYBC01 was used as positive
control for adult worm assay while ivermectin which is known not to
kill adult worms was used for Mf assay. Dimethyl sulphoxide
(DMSO) was used as negative control. Percentage adult female worm
death corresponds to percentage inhibition of formazan formation










Mustakone 2.82 1 218.34 1 0 0
Linoleic acid 5.48 14 280.45 2 2 1
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4.2.2 Extraction and Isolation of Metabolites
The powdered (roots/rhizome) sample (700 g) was mac-
erated in hexane (3 9 3 days each), filtered and concen-
trated on a rotavapor to dryness. Four grams (4 g) of the
crude hexane extract (oil) was dissolved in methylene
chloride and impregnated with 4.0 g of Celite then con-
centrated to dryness over a rotary evaporator. The powder
was chromatographed over 20 g, 60 mesh silica gel column
of size 50 cm long 1.5 cm diameter. The column was
eluted with hexane-EtOAc (starting from 5–70 %), then
with methanol. Eighty (50 mL) fractions were collected,
concentrated and grouped based on TLC profile. The
fractions were combined based on comparative TLC pro-
files. Fractions 1–4 were combined and washed with ace-
tone and to afford a 48 mg white paste designated AMJ1,
Rf = 0.52, TLC (Hex/EtOAc) 1:9).
Major compound (1) of AMJ1, white oil: 13C NMR
(CDCl3, 125 MHz): d 204.1 (C-2), 169.9 (C-4), 121.4
(C-3), 57.0 (C-10), 56.5 (C-1), 56.0 (C-5), 54.5 (C-6), 45.4
(C-7), 36.7 (C-9), 31.8 (C-11), 23.7 (C-15), 22.0 (C-8),
20.4 (C-14), 20.0 (C-13), 19.5 (C-12).
4.3 Treatment of Second Portion of Crude Hexane
Extract of C. articulatus
Ten and half grams (10.5 g) of the crude hexane extract
was treated similarly as mention above with methylene
chloride then impregnation was done with 11.0 g of Celite
and concentrated to dryness over a rotary evaporator. The
powder was chromatographed over 53 g, 60 mesh silica gel
column of size 50 cm long 4 cm diameter. The column was
eluted successively with pure hexane while increasing the
polarity with EtOAc. Sixty (50 mL) fractions were col-
lected, concentrated and grouped based on TLC profile.
Fractions 1–5 were combined and subjected to gel per-
meation via Sephadex LH-20 (CH2Cl2) to afford a white oil
designated 79 mg of AMJ2, Rf = 0.54 TLC (Hex/EtOAc)
2:8).
Compound (2): 13C NMR (CDCl3, 125 MHz): d 180.4
(C-1), 130.1 (C-13), 130.0 (C-9), 128.0 (C-12, C-10), 34.3
(C-2), 31.6 (C-16), 29.8 (C-7), 29.6 (C-15), 29.4 (C-6),
29.2 (C-4, C-5), 27.3 (C-8, C-14), 25.7 (C-11), 25.0 (C-3),
22.9 (C-17), 14.2 (C-18).
4.4 Isolation of O. ochengi Adult Worms
The isolation of O. ochengi adult worms was done as
described previously [15]. The duration from the slaugh-
tering of a cow to the harvesting of parasites from the skin
was always less than 2 h to avoid bacterial contamination.
Briefly, fresh pieces of umbilical cattle skin with palpable
nodules bought from local slaughterhouses were washed,
drained and sterilized with 70 % ethanol. O. ochengi adult
worms were carefully scraped out of the nodules as single
masses and temporarily submerged in 1 mL complete
culture medium, CCM [RPMI-1640 (SIGMA, USA) sup-
plemented with 25 mM HEPES, 2 g/L sodium bicarbonate,
2 mM L-glutamine, 5 % new born calf serum (SIGMA,
USA), 150 units/mL penicillin, 150 lg/mL streptomycin
and 0.5 lg/mL amphotericin B (SIGMA, USA), pH 7.4)]
using 24-well plates. The adult worms were allowed in the
culture medium overnight in a CO2 incubator, during
which period the male worms migrated out of the nodular
masses. Only wells containing viable worms received
treatment with test metabolite. Damaged worms and worms
from putrefied nodules were discarded. The viability of
worms retained for the assay was ascertained by visual and
microscopic examination of adult male worm motility
using an inverted microscope.
4.5 Isolation of O. ochengi Microfilariae
The cattle skin was obtained as described for adult worms.
About 5 skin snips were obtained from different locations of
the skin and incubated separately in small amounts of CCM
for 30 min. Emerged Mfs were qualified and quantified for
O. ochengi species with the aid of an inverted microscope. A
selected piece of skin, rich in O. ochengi Mfs was carefully
shaved with a razor blade, and then rinsed with distilled
water. It was dabbed with a clean tea cloth to eliminate
excess moisture and covered entirely with 70 % ethanol.
The latter was allowed to evaporate completely in a hori-
zontal flow sterile hood. The ethanol treatment was repeated
once. The sterilized skin was tautly attached onto an auto-
claved, cylindrical piece of wood using autoclaved thumb
nails and close (about 1 mm apart) criss-cross cuts were
made into the epidermis and dermis. The assembly was
incubated in the culture medium for 4–6 h. The emerged and
highly motile O. ochengi microfilariae were concentrated by
centrifugation at 4009g for 10 min and then quantified.
4.6 Preparation of Mammalian Cells
Monkey kidney epithelial cells (LLC-MK2) (ATCC, USA)
were cultured at 37 C in humidified air with 5 % CO2 in a
HeraCell-150 incubator (Thermo Electron, Germany) until
the cell layer is almost confluent. The cells were rinsed with a
solution of 0.125 % trypsin and 0.5 mM EDTA in medium
199 (Sigma, USA) and kept in the same mixture for less than
1 h for them to be dislodged. The cell suspension was cen-
trifuged at 5609g for 10 min, the supernatant discarded and
the pellet re-suspended to 2 9 105 cells/mL in CCM. The
cell suspension was dispensed into 96-well microtitre plates
(200 lL/well) and kept in the incubator for 3–5 days for cells
to grow and become fully confluent. These cells served as
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feeder layer for the Mfs assays and were also used for
cytotoxicity studies.
4.7 Preparation of Stock Solutions of Isolated
Metabolites
Twenty-five milligrams (25 mg) of each compound was
weighed and dissolved in microtubes containing 1 mL of
99.9 % pure dimethyl sulfoxide (DMSO) (SIGMA, USA)
to obtain stock solutions of 25 mg/mL. Complete dissolu-
tion was achieved by vortexing. The solutions were stored
at -20 C before they were used in the assays.
4.8 Anti-filarial Screening of Plant-Derived
Metabolites
4.8.1 Primary Screens on Adult Worms
This was done to eliminate inactive metabolites. Adult
worm assays were conducted in 24-well plates (NUNC,
USA) at 37 C in humidified air containing 5 % CO2 for
5 days (120 h) without change of medium. Nodular masses
(each generally containing a few males and a female worm)
were first put in the wells (with 1 mL CCM) without
extract overnight to confirm their viability and for adult
males to migrate from the nodule into the culture medium.
1 mL of CCM containing 1000 lg/mL of extract was then
added into each of quadruplicate wells to give a single final
concentration of 500 lg/mL. Four nodular masses each,
were used in the negative control (2 % DMSO in CCM
only) and in the positive control (10 lM NYBC01, a gold
conjugated compound) wells in which each well also
received only one nodular mass. After 5 days incubation
adult male viability was assessed based on motility scores
using an inverted microscope. Motility score was on a scale
of 4 (vigorous or normal movement of whole worm, cor-
responding to 0 % inhibition of worm motility), 3 (near
normal movement of whole worm or 25 % inhibition of
worm motility), 2 (whole body of worm motile but sluggish
i.e. 50 % inhibition of worm motility), 1 (only head or tail
of worm moving i.e. 75 % inhibition of worm motility), 0
(completely immotile worm i.e. 100 % inhibition of worm
motility). A metabolite was considered active if there was a
100 % inhibition of adult male worm motility; or moder-
ately active for a motility inhibition of 50–99 %; and
inactive if the inhibition was less than 50 %.
Adult female worm viability was assessed by the MTT/
formazan assay in which each nodular mass was placed in a
well of a 48-well microtitre plate containing 500 lL/well of
0.5 mg/mL MTT (Sigma, USA) in incomplete RPMI culture
medium, and then incubated in the dark at 37 C for 30 min.
Adult female worm viability was taken as mean % inhibition
of formazan formation relative to negative control at 120 h
post addition of plant extract. An extract was considered
active on the adult female worm if there was a 90 % or
greater inhibition of formazan formation compared to the
negative controls; or moderately active if the inhibition was
50–89 %. It was considered inactive if the inhibition was
less than 50 %. Adult worm death positively correlates with
inhibition of formazan formation. Inhibition of formazan
formation was assessed by visually observing the worms
after incubation in MTT or by colorimetry. Each nodular
mass was placed in 500 lL of DMSO in a 48-well plate to
allow the colour to elute from the worm for 1 h. After
shaking the plate, 200 lL of the coloured formazan solution
from each well was pipetted into the wells of a microtitre
plate (78 wells) and the optical density read at 490 nm. Adult
female worm viability was taken as mean % inhibition of
formazan formation relative to negative control at 120 h
post addition of the test compound.
Percent inhibition of formazan formation
¼ OD of negative control  OD of treatment
OD of negative control
 100
4.8.2 Primary Screen on Microfilariae
The isolated metabolites were also tested on Mfs at a single
concentration of 500 lg/mL, in triplicate wells. The Mfs
assay was conducted in 96-well microtitre plates (15 mfs in
200 lL CCM per well) at 37 C in humidified air con-
taining 5 % CO2 for 5 days without any change of med-
ium. Fully confluent monkey kidney epithelial cells,
serving as feeder layer, were co-cultured with the Mfs. The
medium used in preparing the feeder cell layer was
removed by a swift decantation before fresh CCM con-
taining plant test metabolite (100 lL) and worms (100 lL)
were immediately added. Ivermectin (20 lg/mL) and 2 %
DMSO served as the positive and negative controls
respectively. Mfs motility scores (viability) were done on a
scale of 0 (immotile), through 0.25 (only tail or head
shaking occasionally), through 0.5 (whole body motile, but
sluggishly or with difficulties), to 1 (almost vigorous to
vigorous motility). Scores were made every 24 h, termi-
nating at 120 h using an inverted microscope. Any culture
with microbial contamination was not considered. Mfs
viability was taken as the mean % reduction at 120 h (day 5)
after addition of drug. A metabolite was considered active
if there was a 100 % reduction in mfs motility; or mod-
erately active for a motility reduction of 50–99 %; and
inactive if the reduction was less than 50 %.
4.8.3 Secondary Screens on Microfilariae and Adult
Worms
This was done to confirm the activity of the metabolites
that showed filaricidal activity in the primary screen, and to
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determine their IC50, IC100 and selectivity index (SI) val-
ues. The metabolites were retested as described under
primary screens at serial dilutions from 500 to 7.81 lg/mL
using 24-well plates for adult worms and 96-well plates for
Mfs. All assays were repeated at least three times and the
results obtained are the mean values at each concentration.
The graphical analysis was done using Microsoft Excel
2010 (Microsoft Corporation, USA). IC50 determination
was done using GraphPad Prism software (version 6).
4.9 Toxicity Studies
4.9.1 Cytotoxicity Studies
This was done as part of the Mfs assay on the active
compounds through observations on the monkey kidney
epithelial cells on day 5. An examination of the deformities
and degree of detachment of the monkey kidney cells was
done. Dead or deformed cells were usually detached from
the bottom of the vessel and were rounded in shape. The
IC50 values for these mammalian cells were determined
graphically using data from microscopy. The selectivity
index (SI) values were calculated using the ratio:
SI ¼ IC50 of drug on mammalian cell=
IC50 of drug on parasite Mfsð Þ
4.9.2 In Silico ‘‘Drug-Likeness’’ of Active Isolated
Compounds
The ‘‘drug-likeness’’ of the isolated compounds was
assessed using Lipinski criteria [9], from computed
molecular properties of the geometry optimized structures.
All 3D molecular structures of the compounds were gen-
erated using the graphical user interface (GUI) of the MOE
software [16] running on a Linux workstation with a
3.5 GHz Intel Core2 Duo processor, and energy minimi-
zation was subsequently carried out using the AM1 semi-
empirical approach implemented in MOPAC24 [17] until a
gradient of 0.001 kcal/mol was reached. The 3D structures
generated were then saved as .mol2 files subsequently
included into a MOE database (.mdb). The MW, NRB,
lipophilicity parameter (log P), HBA, HBD and Lipinski
violations were calculated using the molecular descriptor
calculator included in the QuSAR module of the MOE
package [16].
5 Conclusions
AMJ1 [containing mustakone (1) as major component] and
linoleic acid (2) have been isolated from the roots/rhizomes
of Cyperus articulatus. Our investigations show that both
phytochemicals were able to kill both the microfilariae and
adult worms of O. ochengi in a dose dependent manner.
This study therefore provides the first ever evidence of the
anti-onchcerca efficacy of AJM1-containing mustakone
and linoleic acid. Efforts are being made to identify the
actual compound imparting high activity to AMJ1. Thus
these metabolites may provide a lead for design and
development of new antifilarial agents.
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